Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Clinical Pediatric Endocrinology · 2022 · 31 (3) · 116-143
DOI: 10.1297/cpe.2022-0009 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Pediatric Endocrinology, 2022. Verfasst von Tomohiro Ishii und 14 weiteren Autor:innen. Beteiligte Einrichtung: Differences of Sex Development (DSD) and Adrenal Disorders Committee, Japanese Society for Pediatric Endocrinology. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Differences of Sex Development (DSD) and Adrenal Disorders Committee, Japanese Society for Pediatric Endocrinology.
- Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
- Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
- Committee on Mass Screening, Japanese Society for Pediatric Endocrinology.
- Department of Pediatrics, Saitama City Hospital, Saitama, Japan.
- Department of Pediatrics, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Zitieren
APA
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura-Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., Satoh, H., Yoshino, K., Otsuki, M., Katabami, T., & Tajima, T. (2022). Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision). Clinical Pediatric Endocrinology, 31(3), 116-143. https://doi.org/10.1297/cpe.2022-0009
Vancouver
Ishii T, Kashimada K, Amano N, Takasawa K, Nakamura-Utsunomiya A, Yatsuga S, et al. Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision). Clinical Pediatric Endocrinology. 2022;31(3):116-143. doi:10.1297/cpe.2022-0009
BibTeX
@article{Ishii2022,
author = {Ishii, Tomohiro and Kashimada, Kenichi and Amano, Naoko and Takasawa, Kei and Nakamura-Utsunomiya, Akari and Yatsuga, Shuichi and Mukai, Tokuo and Ida, Shinobu and Isobe, Mitsuhisa and Fukushi, Masaru and Satoh, Hiroyuki and Yoshino, Kaoru and Otsuki, Michio and Katabami, Takuyuki and Tajima, Toshihiro},
title = {Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)},
journal = {Clinical Pediatric Endocrinology},
year = {2022},
volume = {31},
number = {3},
pages = {116--143},
doi = {10.1297/cpe.2022-0009}
}
EUVIMED